Proteomic profiling across breast cancer cell lines and models

Area of Science:

• Proteomics
• Cancer Biology
• Genomics

Background:

• Breast cancer exhibits diverse molecular subtypes impacting treatment.
• Cell line models are crucial for understanding cancer biology and drug development.
• Quantitative proteomics offers a deep molecular profiling approach.

Purpose of the Study:

• To perform comprehensive quantitative proteomics on human breast cancer cell line models.
• To identify and characterize molecular subtypes within these cell lines.
• To make high-throughput proteomic datasets publicly available for research.

Main Methods:

• Quantitative proteomics analysis of 60 human-derived breast cancer cell lines.
• Depth of proteomic coverage reached approximately 13,000 proteins.
• Quality and reproducibility assessment of high-throughput datasets.

Main Results:

• Successfully identified and characterized breast cancer subtypes based on proteomic data.
• Demonstrated that molecular subtypes align with known transcriptional subtypes.
• Confirmed preservation of molecular subtypes even with limited protein feature sets.

Conclusions:

• Molecular subtypes of breast cancer are robust and detectable through quantitative proteomics.
• The generated proteomic datasets are valuable public resources for cancer research.
• These datasets can inform drug response prediction, pathway modeling, and biomarker discovery.